By Senad Karaahmetovic

Nelson Peltz (NYSE:) is an American activist investor and businessman who will be joining the Unilever board. The move puts pressure on Unilever, a consumer goods company that seeks to revamp its strategies.

Peltz, who holds a roughly 1.5% stake in Unilever, is expected to join the company as a non-executive director in July and become a member of the board’s compensation committee.

The move comes as Unilever attempts to remodel its business strategy after its unsuccessful $63 billion takeover of GSK’s consumer healthcare business a few months ago.

Peltz released a statement saying that he and his team look forward “to working together with management and board to help Unilever’s strategy and operations, sustainability, shareholder value, and sustainable growth.”

Peltz, CEO and founding partner of the asset management firm Trian, has historically expressed interest in consumer-focused businesses and pushed for strategic changes at the hedge fund’s portfolio companies.

Four years ago, Trian pushed for a series of changes at Unilever’s competitor P&G (NYSE:). After a couple of months-long proxy fight, Peltz joined P&G’s board.

BofA analyst Eva Quiroga believes Peltz is likely to focus on improving the organic top-line growth, which is described as the company’s “Achilles’ heel”.

“We believe that to address Unilever’s organic topline growth woes, focus will likely be on increasing investment in the core business (Beauty & Personal Care), while reducing the exposure to slow-growing categories (notably F&R) – and potentially separating the business by category/ regional fault-lines,” Quiroga told clients in a note.

RBC and Credit Suisse analysts praised Peltz’s appointment to Unilever’s board, saying that the activist investor could bring positive amendments to the company’s culture.

RBC analysts wrote that clients could benefit from the presence or participation of activist investors to drive cooperation among Unilever shareholders.

Unilever shares were up 6.6% Tuesday pre-market.